Timolol- Dorzolamide- Latanoprost P-F (0.5/2.0/0.005%) ophthalmic drops, packaged in 5mL bottles, Rx only, ImprimisRx NJ 1705 Route 46 West, Suite 4, Ledgewood, NJ 07852 (844) 446-6979
Published August 7, 2019 · Recall initiated: July 17, 2019
Summary
FDA records drug Class II recall D-1579-2019, published August 7, 2019 and initiated July 17, 2019. Recalling firm: ImprimisRx NJ; Status: Terminated; Reported quantity: 246 bottles; Lot: Lot #: 03132019@2, Exp. 09/17/2019; 05102019@2, Exp. 11/02/2019. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent Drug
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- ImprimisRx NJ
- Distributor
- Nationwide within the United States
- Lot
- Lot #: 03132019@2, Exp. 09/17/2019; 05102019@2, Exp. 11/02/2019
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDATimolol-Latanoprost (0.5/0.005%) ophthalmic drops, Compounded, 5 mL bottle, Imprimis Rx, Ledgewood, NJ.November 23, 2022
- FDAPapaverine/Phentolamine/Alprostadil/Atropine 30 mg/2 mg/50 mcg/0.15 mg/mL Injectable, 2.5 mL Vial, Rx only,August 7, 2019
- FDAEquate Night-time Sleep Aide (Diphenhydramine HCl), 50 mg, Alcohol Free, Berry Flavor, 12 Fl. Oz. (354 mL),August 7, 2019
- FDAPapaverine/Phentolamine/Alprostadil 30 mg/2 mg/50 mcg/mL Injectable, 2.5 mL Vial, Rx only, Compounded by WiseAugust 7, 2019
- FDAGablofen (baclofen injection), 50 mcg/mL, Single Use Syringe, Rx only, packaged in a box containing one 1 mLAugust 7, 2019
- FDAPapaverine/Phentolamine/Alprostadil 30 mg/2 mg/30 mcg/mL Injectable, 2.5 mL Vial, Rx only, Compounded by WiseAugust 7, 2019
Questions about this recall
Was Timolol- Dorzolamide- Latanoprost P-F (0.5/2.0/0.005%) ophthalmic drops, packaged in 5mL bottles, Rx only, ImprimisRx NJ 1705 Route 46 West, Suite 4, Ledgewood, NJ 07852 (844) 446-6979 recalled?
Yes. FDA published recall D-1579-2019 on August 7, 2019. Reported hazard: Subpotent Drug
What should I do if I have this product?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit